Expert Insights

At the 2023 Great Debates and Updates in Gastrointestinal Cancers meeting in Chicago, Gary Deng, MD, PhD, highlighted the pillars of cancer wellness and explained how to incorporate integrative medicine into the management of patients with...

Suneel Kamath, MD, gives an overview of his talk on circulating tumor DNA from the 2023 Great Debates and Updates in Gastrointestinal Malignancies meeting in Chicago, IL.

Jung-Yun Lee, MD, discusses the final primary analysis from a phase 2 study that explored durvalumab plus tremelimumab added to frontline neoadjuvant chemotherapy for patients with advanced ovarian cancer.

At the 2023 Great Debates and Updates in Gastrointestinal Malignancies in Chicago, Nataliya Uboha, MD, PhD, gave an overview of her presentation on biomarkers and targeting treatment for gastroesophageal cancers.

Talha Munir, MD, St. James's Hospital in Leeds, United Kingdom, highlights his treatment choices for the case of a 76-year-old patient with chronic lymphocytic leukemia.

Brian Slomovitz, MD, discusses his presentation on the use of letrozole plus ribociclib for patients with recurrent low-grade serous carcinoma of the ovaries at the SGO Annual Meeting on Women's Cancer.

Timothy Pawlik, MD, PhD, MPH, gives an overview of IDH and FGFR mutations as molecular targets for cholangiocarcinoma.

At the 2023 ACRO Radiation Oncology Summit, Manisha Palta, MD, discussed the role of radiation therapy in the neoadjuvant setting for patients with pancreatic cancer.

At the 2023 ACRO Radiation Oncology Summit, Gerard Morton, MD, discusses the different methods of radiation dose intensification for patients with high-risk prostate cancer.

At the 2023 ACRO Radiation Oncology Summit, Mylin Torres, MD, gave a presentation exploring the option of 5-fraction radiation regimens for patients with early-stage breast cancer.